Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
14%
Ph phase_4
2
29%
Ph phase_2
2
29%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Withdrawn1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)

Trials by Status

withdrawn114%
completed457%
not_yet_recruiting114%
unknown114%

Recent Activity

0 active trials
Showing 5 of 7
not_yet_recruiting

Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy

NCT07499882
unknownphase_2

Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer

NCT00996983
withdrawnphase_4

Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy

NCT01992562
completed

Patient Registry of Intrathecal Ziconotide Management(PRIZM)

NCT01888120
completedphase_3

Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain

NCT00076544
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07499882

Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy

Not Yet Recruiting
NCT00996983Phase 2

Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer

Unknown
NCT01992562Phase 4

Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy

Withdrawn
NCT01888120

Patient Registry of Intrathecal Ziconotide Management(PRIZM)

Completed
NCT00076544Phase 3

Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain

Completed
NCT01373983Phase 4

Intrathecal Bolus Doses of Ziconotide

Completed
NCT00002160Phase 2

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7